tiprankstipranks
Trending News
More News >
Universal Health (UHS)
NYSE:UHS
US Market
Advertisement

Universal Health (UHS) Ratios

Compare
556 Followers

Universal Health Ratios

UHS's free cash flow for Q3 2025 was $0.91. For the 2025 fiscal year, UHS's free cash flow was decreased by $ and operating cash flow was $0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.03 1.40 1.33 1.14 1.32
Quick Ratio
0.96 1.29 1.21 1.04 1.25
Cash Ratio
0.04 0.06 0.05 0.06 0.49
Solvency Ratio
0.25 0.17 0.17 0.22 0.21
Operating Cash Flow Ratio
0.90 0.63 0.52 0.45 0.95
Short-Term Operating Cash Flow Coverage
3.86 6.39 6.67 7.83 6.02
Net Current Asset Value
$ -4.79B$ -4.95B$ -4.99B$ -4.63B$ -3.79B
Leverage Ratios
Debt-to-Assets Ratio
0.33 0.38 0.39 0.35 0.31
Debt-to-Equity Ratio
0.71 0.87 0.89 0.75 0.66
Debt-to-Capital Ratio
0.41 0.47 0.47 0.43 0.40
Long-Term Debt-to-Capital Ratio
0.35 0.43 0.44 0.40 0.35
Financial Leverage Ratio
2.12 2.27 2.28 2.15 2.13
Debt Service Coverage Ratio
2.42 3.80 5.19 8.25 3.15
Interest Coverage Ratio
12.70 5.81 7.91 16.29 12.78
Debt to Market Cap
0.32 0.47 0.47 0.39 0.33
Interest Debt Per Share
81.80 80.33 73.83 56.27 50.56
Net Debt to EBITDA
1.93 3.01 3.15 2.31 1.59
Profitability Margins
Gross Profit Margin
90.34%89.27%89.00%88.71%88.86%
EBIT Margin
11.71%8.04%7.38%10.89%11.75%
EBITDA Margin
15.25%12.21%12.26%15.25%16.18%
Operating Profit Margin
11.47%8.23%7.49%10.78%11.75%
Pretax Profit Margin
10.76%6.58%6.46%10.23%10.83%
Net Profit Margin
8.09%5.03%5.04%7.84%8.17%
Continuous Operations Profit Margin
8.24%5.04%4.90%7.81%8.24%
Net Income Per EBT
75.19%76.33%77.99%76.67%75.39%
EBT Per EBIT
93.83%80.01%86.32%94.88%92.18%
Return on Assets (ROA)
8.96%5.14%5.01%7.57%7.00%
Return on Equity (ROE)
19.85%11.67%11.41%16.28%14.94%
Return on Capital Employed (ROCE)
16.00%9.83%8.67%12.27%12.35%
Return on Invested Capital (ROIC)
11.48%7.35%6.45%9.22%9.03%
Return on Tangible Assets
12.11%7.15%7.05%10.86%9.84%
Earnings Yield
9.52%6.79%6.56%9.27%8.07%
Efficiency Ratios
Receivables Turnover
6.57 6.38 6.64 7.24 6.69
Payables Turnover
0.70 2.50 2.32 2.17 2.26
Inventory Turnover
7.25 7.06 6.75 6.90 6.76
Fixed Asset Turnover
2.31 2.18 2.10 2.03 2.02
Asset Turnover
1.11 1.02 0.99 0.97 0.86
Working Capital Turnover Ratio
44.04 20.10 29.70 23.41 20.04
Cash Conversion Cycle
-412.51 -37.33 -48.54 -65.19 -53.11
Days of Sales Outstanding
55.53 57.20 54.96 50.43 54.60
Days of Inventory Outstanding
50.38 51.67 54.10 52.90 53.96
Days of Payables Outstanding
518.43 146.20 157.60 168.52 161.66
Operating Cycle
105.91 108.87 109.06 103.33 108.55
Cash Flow Ratios
Operating Cash Flow Per Share
44.40 18.29 13.62 10.71 27.75
Free Cash Flow Per Share
21.32 7.57 3.58 0.34 19.12
CapEx Per Share
23.07 10.72 10.04 10.37 8.63
Free Cash Flow to Operating Cash Flow
0.48 0.41 0.26 0.03 0.69
Dividend Paid and CapEx Coverage Ratio
1.83 1.59 1.26 0.96 3.14
Capital Expenditure Coverage Ratio
1.92 1.71 1.36 1.03 3.21
Operating Cash Flow Coverage Ratio
0.56 0.24 0.19 0.19 0.56
Operating Cash Flow to Sales Ratio
0.17 0.09 0.07 0.07 0.20
Free Cash Flow Yield
9.48%4.97%2.54%0.26%13.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.52 14.72 15.25 10.79 12.39
Price-to-Sales (P/S) Ratio
0.85 0.74 0.77 0.85 1.01
Price-to-Book (P/B) Ratio
2.00 1.72 1.74 1.76 1.85
Price-to-Free Cash Flow (P/FCF) Ratio
10.57 20.14 39.32 381.63 7.19
Price-to-Operating Cash Flow Ratio
5.07 8.34 10.34 12.11 4.96
Price-to-Earnings Growth (PEG) Ratio
1.06 1.21 -0.66 1.35 0.59
Price-to-Fair Value
2.00 1.72 1.74 1.76 1.85
Enterprise Value Multiple
7.52 9.07 9.42 7.86 7.84
Enterprise Value
19.47B 15.81B 15.47B 15.14B 14.67B
EV to EBITDA
7.51 9.07 9.42 7.86 7.84
EV to Sales
1.15 1.11 1.15 1.20 1.27
EV to Free Cash Flow
14.19 30.14 59.04 540.15 9.02
EV to Operating Cash Flow
6.81 12.47 15.53 17.14 6.21
Tangible Book Value Per Share
51.40 31.63 27.11 26.11 28.70
Shareholders’ Equity Per Share
112.35 88.70 80.97 73.80 74.27
Tax and Other Ratios
Effective Tax Rate
0.23 0.24 0.24 0.24 0.24
Revenue Per Share
264.04 206.03 183.26 153.20 135.89
Net Income Per Share
21.37 10.35 9.24 12.02 11.10
Tax Burden
0.75 0.76 0.78 0.77 0.75
Interest Burden
0.92 0.82 0.88 0.94 0.92
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.47 0.51 0.51 0.50 0.50
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.38 1.77 1.52 0.89 2.48
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis